Correlation Between Amylyx Pharmaceuticals and Mesoblast

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Mesoblast, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Mesoblast.

Diversification Opportunities for Amylyx Pharmaceuticals and Mesoblast

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Amylyx and Mesoblast is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Mesoblast go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Mesoblast

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to under-perform the Mesoblast. But the etf apears to be less risky and, when comparing its historical volatility, Amylyx Pharmaceuticals is 1.12 times less risky than Mesoblast. The etf trades about -0.01 of its potential returns per unit of risk. The Mesoblast is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  183.00  in Mesoblast on November 9, 2024 and sell it today you would earn a total of  1,686  from holding Mesoblast or generate 921.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.25%
ValuesDaily Returns

Amylyx Pharmaceuticals  vs.  Mesoblast

 Performance 
       Timeline  
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Amylyx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's essential indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the ETF investors.
Mesoblast 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mesoblast are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Mesoblast displayed solid returns over the last few months and may actually be approaching a breakup point.

Amylyx Pharmaceuticals and Mesoblast Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amylyx Pharmaceuticals and Mesoblast

The main advantage of trading using opposite Amylyx Pharmaceuticals and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.
The idea behind Amylyx Pharmaceuticals and Mesoblast pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.